Screening Group, Early Detection and Prevention Section, International Agency for Research on Cancer, Lyon, France.
Department of Epidemiology and Public Health, Kanazawa Medical University, Ishikawa, Japan.
Lancet Oncol. 2016 Jul;17(7):e305-e312. doi: 10.1016/S1470-2045(16)30121-8.
Since the mid-1990s, there has been an increasing incidence of, and mortality from, cervical and breast cancers in Japan. Such an increase has raised concerns over the efficiency of Japan's screening programmes for these cancers. Although citizens benefit from universal health coverage, the Japanese health insurance system mostly focuses on tertiary prevention and disease treatment, while secondary prevention (screening) is low priority. Citizens have multiple opportunities to be screened for cancer-either through programmes organised by municipalities, or individual or collective, opportunistic and comprehensive health check-ups on a voluntary basis. Despite this, however, participation is as low as 35% of the target population for both cancers. In this Policy Review, we discuss the challenges in the prevention of breast and cervical cancers in Japan, particularly focusing on the structure of the National Health Insurance system and the National Cancer Control Plan, reasons for low participation as a result of social and political attitudes, as well as providing recommendations to overcome these challenges. Japanese women would benefit from new measures to increase participation, a national data surveillance programme to monitor screening activities, and the implementation of a quality assurance system among all providers.
自 20 世纪 90 年代中期以来,日本宫颈癌和乳腺癌的发病率和死亡率一直在上升。这种上升引起了人们对日本这些癌症筛查计划效率的关注。尽管公民受益于全民健康覆盖,但日本的健康保险制度主要侧重于三级预防和疾病治疗,而二级预防(筛查)的优先级较低。公民有多种机会接受癌症筛查——无论是通过市政组织的计划,还是个人或集体的、机会性的和全面的自愿健康检查。尽管如此,这两种癌症的参与率都只有目标人群的 35%。在本政策审查中,我们讨论了日本预防乳腺癌和宫颈癌的挑战,特别是重点关注国家健康保险制度和国家癌症控制计划的结构、由于社会和政治态度导致的低参与率的原因,并提供了克服这些挑战的建议。日本妇女将受益于增加参与度的新措施、监测筛查活动的国家数据监测计划,以及在所有提供者中实施质量保证系统。